Thursday, 09 December 2021

LIVE Video

WHO comments on the rising cases of Omicron Variant
Videos

Inside Magazine
 
Why’s BioPharma BREAKING R&D SHACKLES?

The Indian industry bore witness to biotech companies collaborating with vaccine manufacturers, vaccine technologies being transferred, licenses to manufacture several drugs granted to pharma companies, among other notable developments. These collaborations and partnerships have furthered R&D, commercialisation and distribution of several critical drugs throughout 2021. However, key barriers to R&D-based innovation still persist in the Indian pharma market that needs to be sorted out soon. We shall take a closer look at the industry’ quest to realise even more, swift innovations and fewer hindrances. 
 

 For Feedback, please email us at : communications@mmactiv.com
--

Sign up here to access BioSpectrum India Flip Book.

BioSpectrum Infomercial
//Survey Form JS Starts //Survey Form JS Ends